{"url":"https://lda.senate.gov/api/v1/filings/f2d122c0-4f7b-49f3-b2ca-d6603acdbdbd/","filing_uuid":"f2d122c0-4f7b-49f3-b2ca-d6603acdbdbd","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2020,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/f2d122c0-4f7b-49f3-b2ca-d6603acdbdbd/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Thomas Hodgkins","dt_posted":"2021-02-16T15:18:09.823000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"4747 Pinnacle Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Bradenton","registrant_state":"FL","registrant_zip":"34208","registrant":{"id":401105635,"url":"https://lda.senate.gov/api/v1/registrants/401105635/","house_registrant_id":null,"name":"BEACON STRATEGIES","description":"Consulting and Government Relations","address_1":"4747 Pinnacle Drive","address_2":null,"address_3":null,"address_4":null,"city":"Bradenton","state":"FL","state_display":"Florida","zip":"34208","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"THOMAS HODGKINS","contact_telephone":"+1 410-703-6929","dt_updated":"2023-06-06T16:25:15.552613-04:00"},"client":{"id":207208,"url":"https://lda.senate.gov/api/v1/clients/207208/","client_id":113,"name":"SAOL THERAPEUTICS","general_description":"Pharmaceutical development","client_government_entity":false,"client_self_select":null,"state":"GA","state_display":"Georgia","country":"US","country_display":"United States of America","ppb_state":"GA","ppb_state_display":"Georgia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Pharmaceutical manufacturing","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73433,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"HODGKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73437,"prefix":null,"prefix_display":null,"first_name":"KRISTEN","nickname":null,"middle_name":null,"last_name":"GULLOTT","suffix":null,"suffix_display":null},"covered_position":"Special Assistant, US Department of Energy, Office of Fossil Energy, 2002-2003 Policy Advisor, US Department of Energy, Office of Fossil Energy, 2003-2004","new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Pharmaceutical Manufacturing","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73437,"prefix":null,"prefix_display":null,"first_name":"KRISTEN","nickname":null,"middle_name":null,"last_name":"GULLOTT","suffix":null,"suffix_display":null},"covered_position":"Special Assistant, US Department of Energy, Office of Fossil Energy, 2002-2003 Policy Advisor, US Department of Energy, Office of Fossil Energy, 2003-2004","new":false},{"lobbyist":{"id":73433,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"HODGKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}